Editorial | Aducanumabe para doença de Alzheimer?

Aducanumab for Alzheimer’s disease? – The BMJ

Relacionado: FDA approvement of Alzheimer’s drug sparks controversy among doctors.

Comentário no Twitter

Our editorial for @bmj_latest on the controversial #Aducanumab approval and what it means for patients, clinicians and researchers.
With @seb_walsh, Richard Milne @ethicsWCS, Carol Brayne @CamPubHealth https://t.co/mnhh4F1gKK

— Richard Merrick (@r_merrick) July 9, 2021